Covidien (COV) Tops Q1 EPS by 2c
Tweet
Share
E-mailGet Alerts COV Hot Sheet
Price: $106.71 --0%
Financial Fact:
Income from continuing operations before income taxes: 583M
Today's EPS Names:
VAXX, EGRX, AFIB, More
Financial Fact:
Income from continuing operations before income taxes: 583M
Today's EPS Names:
VAXX, EGRX, AFIB, More
Join SI Premium – FREE
Covidien (NYSE: COV) reported Q1 EPS of $1.05, $0.02 better than the analyst estimate of $1.03. Revenue for the quarter came in at $2.95 billion versus the consensus estimate of $2.9 billion.
For earnings history and earnings-related data on Covidien (COV) click here.
For earnings history and earnings-related data on Covidien (COV) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Upgrades Aviva Plc (AV/:LN) (AIVAF) to Overweight
- Goldman Sachs raises Europe stock earnings forecast to 15%
- Bernstein SocGen Group Reiterates Outperform Rating on IREN Ltd. (IREN)
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
